查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1934171

傷口護理市場 - 全球產業規模、佔有率、趨勢、機會及預測（按治療方法、傷口類型、應用、最終用戶、地區和競爭格局分類，2021-2031年）

Wound Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy, By Wound Type, By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球傷口護理市場預計將從 2025 年的 234.7 億美元成長到 2031 年的 337.9 億美元，複合年成長率為 6.26%。

此領域涵蓋多種產品，包括醫用敷料、活性療法以及旨在促進急性和慢性傷害止血和組織再生的專用器械。推動這一成長的關鍵因素是全球文明病（尤其是糖尿病）盛行率的上升，這導致需要長期管理的複雜潰瘍的發生率增加。根據國際糖尿病聯盟 (IDF) 預測，到 2024 年，全球將有約 5.89 億成年人患有糖尿病，這將形成一個皮膚併發症高風險族群。此外，人口老化導致手術干預頻率增加，從而對術後護理產生了持續的需求。

市場概覽
預測期 2027-2031
市場規模：2025年 234.7億美元
市場規模：2031年 337.9億美元
複合年成長率：2026-2031年 6.26%
成長最快的細分市場 醫院和診所
最大的市場 北美洲

然而，先進生物活性療法的高昂成本是市場擴張的一大障礙。新興國家嚴格的報銷政策往往迫使​​醫療服務提供者轉向傳統的、成本較低的替代方案。這種經濟障礙阻礙了高品質治療方案的廣泛應用，並限制了價格敏感型地區的市場成長。

市場促進因素

老年人口的快速成長及其伴隨而來的老齡化易感性正在從根本上改變市場模式。老年人的生理變化使其患有難以癒合的慢性疾病的風險顯著增加，從而催生了對持續臨床干預和治療方案的需求。隨著醫療保健機構尋求有效治療方法複雜潰瘍和壓瘡的方法，這種人口結構的變化正直接推動主要產業參與者的商業性成長。例如，根據科樂普公司於2024年11月發布的2023/24年度報告，該公司的高級創傷護理業務在全球市場強勁需求的推動下實現了10%的內部成長。這一成長凸顯了全球人口老化與對專業傷口管理產品日益成長的需求之間的重要連結。

此外，先進傷口敷料和智慧療法的技術創新是推動市場發展的另一個關鍵因素。製造商正日益將負壓傷口治療和生物活性材料等主動機制融入產品中，以促進傳統敷料無法有效治療的複雜病例的癒合。這些創新透過縮短復健時間改善了患者的治療效果，同時減輕了醫療保健系統的整體經濟負擔。為了反映這一趨勢，史密斯醫療（Smith & Nephew）在2024年2月發布的「2023年第四季及全年業績」報告中指出，其先進傷口護理設備部門的收入實現了14.9%的潛在成長。此外，莫爾尼克（Molnrike）公佈的2024會計年度和2023會計年度淨銷售額均創歷史新高，達到19.24億歐元，進一步印證了該部門的強勁財務表現，也印證了市場的良好前景。

市場挑戰

先進生物活性療法的高成本嚴重阻礙了全球傷口護理市場的擴張。細胞和組織療法等高價值產品的高價往往超出公共醫療系統和私人支付方的預算，尤其是在對價格敏感的發展中地區。因此，健保機構設定了嚴格的資格標準，迫使醫療服務提供者優先選擇傳統的低成本敷料，而非更有效但價格更高的再生醫學療法。這種經濟限制直接抑制了先進療法的應用，降低了市場滲透率和整體收入潛力。

慢性傷口併發症的整體治療成本巨大，加劇了醫療負擔，迫使管理者限制每位患者的支出。根據英國糖尿病協會（Diabetes UK ）統計，到2024年，治療糖尿病相關併發症（包括複雜的足部潰瘍和截肢）的年度醫療費用將達到62億英鎊。如此龐大的傷口管理支出使得嚴格的成本控制措施勢在必行，從而限制了用於先進生物活性療法的資金，並阻礙了該領域的發展。

市場趨勢

生物活性和組織工程療法的興起正在迅速改變複雜難癒合傷口的治療標準。市場正從傳統的被動商業性轉向以細胞和組織為基礎的產品（CTP），這些產品在結構上模擬細胞外基質並主動促進組織再生。這一趨勢的特點是，先進的皮膚替代物在臨床實踐中得到加速應用，這主要得益於它們能夠閉合傳統治療方法無效的頑固性潰瘍。該行業近期的財務業績也印證了對這種高品質再生醫學解決方案的強勁需求。 Organogenesis Holdings, Inc. 於 2025 年 2 月發布的「2024 年第四季財務業績」顯示，其先進創傷護理產品的淨銷售額年增 27%，凸顯了這些專業治療方法的市場顯著擴張。

同時，採用內建即時感測器的智慧敷料已成為一項關鍵趨勢，推動醫療領域從被動治療轉向主動監測。製造商正擴大將診斷微型感測器直接整合到紡織品中，以持續追蹤溫度和壓力等生理參數，從而在糖尿病足潰瘍等併發症發生之前就進行早期檢測。將數位健康功能整合到實體敷料中，代表著預防醫學的新前沿，並吸引了大量資本投資。例如，2025年1月，Molnlycke Healthcare宣布向糖尿病足潰瘍管理系統公司Siren投資800萬美元，以支持其配備感測器的穿戴式技術的發展，該技術可用於早期檢測患者的組織損傷。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球傷口護理市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 治療方法（器械治療、血小板治療、細胞治療、傷口敷料、其他）
    • 依傷口類型（腹部皮下傷口、創傷/感染性傷口、雙側乳房縮小術傷口、其他）
    • 用於（燒燙傷、潰瘍、割傷/撕裂傷等）
    • 按最終使用者（醫院/診所、門診手術中心、居家醫療、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美傷口護理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲傷口護理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區傷口護理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲傷口護理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲傷口護理市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球傷口護理市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • 3M Company
  • ConvaTec Group PLC
  • MOlnlycke Health Care AB
  • Smith & Nephew plc
  • Organogenesis Incx
  • Coloplast A/S
  • MiMedx Group Inc.
  • Integra LifeSciences Corporation
  • Johnson & Johnson
  • Medtronic Plc

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 14829

The Global Wound Treatment Market is projected to expand from USD 23.47 Billion in 2025 to USD 33.79 Billion by 2031, reflecting a CAGR of 6.26%. This sector encompasses a range of products, including medical dressings, active therapies, and specialized devices intended to facilitate hemostasis and encourage tissue regeneration in both acute and chronic injuries. A primary factor driving this growth is the rising global prevalence of lifestyle-related diseases, particularly diabetes, which leads to a higher incidence of complex ulcers necessitating extended management. According to the International Diabetes Federation, approximately 589 million adults were living with diabetes worldwide in 2024, creating a significant patient demographic susceptible to skin complications. Furthermore, an aging population contributes to sustained demand for postsurgical care due to the increased frequency of surgical interventions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 23.47 Billion
Market Size 2031USD 33.79 Billion
CAGR 2026-20316.26%
Fastest Growing SegmentHospitals & Clinics
Largest MarketNorth America

However, a major obstacle hindering market expansion is the prohibitive cost associated with advanced bioactive therapies. Rigid reimbursement policies in emerging economies frequently compel healthcare providers to rely on traditional, less expensive alternatives. This economic barrier prevents the widespread adoption of premium treatment solutions and restricts growth in regions where price sensitivity is a critical factor.

Market Driver

The rapid growth of the geriatric population and their inherent susceptibility to age-related wounds are fundamentally reshaping the market landscape. As older adults undergo physiological changes, they face a significantly higher risk of developing hard-to-heal chronic conditions, creating a consistent need for clinical interventions and therapeutic solutions. This demographic shift directly fuels commercial growth for key industry players as healthcare providers seek effective treatments for complex ulcers and pressure injuries. For instance, Coloplast's 'Annual Report 2023/24', published in November 2024, reported that its Advanced Wound Care business achieved an organic growth rate of 10%, driven largely by strong demand across global markets. This increase underscores the critical link between an aging global populace and the escalating requirement for specialized wound management products.

Additionally, technological advancements in advanced wound dressings and smart therapies act as a second pivotal force propelling market progression. Manufacturers are increasingly integrating active mechanisms, such as negative pressure wound therapy and bioactive materials, to accelerate healing in complex cases where traditional dressings are insufficient. These innovations improve patient outcomes while reducing the overall economic burden on healthcare systems by shortening recovery times. Reflecting this trend, Smith+Nephew reported in February 2024, within their 'Fourth Quarter and Full Year 2023 Results', that Advanced Wound Devices revenue increased by 14.9% on an underlying basis. Further validating the sector's financial health, Molnlycke reported record high annual net sales of EUR 1,924 million for the fiscal year 2023 in 2024, confirming the market's positive trajectory.

Market Challenge

The prohibitive cost associated with advanced bioactive therapies presents a formidable barrier to the expansion of the Global Wound Treatment Market. High pricing for these premium products-such as cellular and tissue-based solutions-often exceeds the budgetary constraints of public health systems and private payers, particularly in price-sensitive developing regions. Consequently, reimbursement bodies enforce strict coverage criteria, forcing healthcare providers to prioritize traditional, lower-cost dressings over more effective but expensive regenerative solutions. This economic limitation directly stifles the volume of adoption for advanced therapies, reducing their market penetration and overall revenue potential.

This financial strain is intensified by the massive aggregate expense of managing chronic wound complications, which compels administrators to limit per-patient spending. According to Diabetes UK, in 2024, the annual cost to the healthcare system for treating diabetes-related complications, including complex foot ulcers and amputations, reached £6.2 billion. This substantial baseline expenditure on wound management necessitates rigorous cost-containment measures, thereby restricting the funds available for sophisticated bioactive treatments and hampering the sector's growth trajectory.

Market Trends

The rise of Bioactive and Regenerative Tissue Engineering Therapies is rapidly redefining the standard of care for complex, hard-to-heal injuries. Moving away from traditional passive treatments, the market is witnessing a decisive commercial shift toward cellular and tissue-based products (CTPs) that structurally mimic the extracellular matrix to actively stimulate tissue regeneration. This trend is characterized by the accelerated adoption of advanced skin substitutes in clinical settings, driven by their ability to close refractory ulcers that fail to respond to conventional management. This robust demand for premium regenerative solutions is substantiated by recent financial performance in the sector; according to Organogenesis Holdings Inc., in their 'Fourth Quarter 2024 Financial Results' released in February 2025, net revenue from Advanced Wound Care products increased by 27% compared to the prior year, highlighting the significant market expansion of these specialized therapies.

Simultaneously, the adoption of Smart Dressings with Embedded Real-Time Sensors is emerging as a critical trend, shifting the sector from reactive treatment to proactive monitoring. Manufacturers are increasingly embedding diagnostic microsensors directly into textiles to continuously track physiological parameters such as temperature and pressure, enabling the early detection of complications like diabetic foot ulcers before they develop. This integration of digital health capabilities into physical dressings represents a new frontier in preventative care, attracting substantial capital investment. For example, in January 2025, Molnlycke Health Care announced a USD 8 million investment in Siren, a diabetic foot ulcer management system company, to support the expansion of sensor-based wearable technologies designed for the early detection of patient tissue damage.

Key Market Players

  • 3M Company
  • ConvaTec Group PLC
  • MOlnlycke Health Care AB
  • Smith & Nephew plc
  • Organogenesis Incx
  • Coloplast A/S
  • MiMedx Group Inc.
  • Integra LifeSciences Corporation
  • Johnson & Johnson
  • Medtronic Plc

Report Scope

In this report, the Global Wound Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Wound Treatment Market, By Therapy

  • Instrumental Based Therapy
  • Platelet Therapy
  • Cell Therapy
  • Wound Dressing
  • Others

Wound Treatment Market, By Wound Type

  • Subcutaneous Abdominal Wound
  • Traumatic & Infected Wound
  • Bilateral Reduction Mammaplasty Wound
  • Others

Wound Treatment Market, By Application

  • Burns
  • Ulcers
  • Cuts & Lacerations
  • Others

Wound Treatment Market, By End User

  • Hospitals & Clinics
  • Ambulatory Surgery Centers
  • Homecare
  • Others

Wound Treatment Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Wound Treatment Market.

Available Customizations:

Global Wound Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Wound Treatment Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Therapy (Instrumental Based Therapy, Platelet Therapy, Cell Therapy, Wound Dressing, Others)
    • 5.2.2. By Wound Type (Subcutaneous Abdominal Wound, Traumatic & Infected Wound, Bilateral Reduction Mammaplasty Wound, Others)
    • 5.2.3. By Application (Burns, Ulcers, Cuts & Lacerations, Others)
    • 5.2.4. By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Homecare, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America Wound Treatment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Therapy
    • 6.2.2. By Wound Type
    • 6.2.3. By Application
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Wound Treatment Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Therapy
        • 6.3.1.2.2. By Wound Type
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada Wound Treatment Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Therapy
        • 6.3.2.2.2. By Wound Type
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico Wound Treatment Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Therapy
        • 6.3.3.2.2. By Wound Type
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End User

7. Europe Wound Treatment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Therapy
    • 7.2.2. By Wound Type
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Wound Treatment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Therapy
        • 7.3.1.2.2. By Wound Type
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. France Wound Treatment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Therapy
        • 7.3.2.2.2. By Wound Type
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom Wound Treatment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Therapy
        • 7.3.3.2.2. By Wound Type
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Wound Treatment Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Therapy
        • 7.3.4.2.2. By Wound Type
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Wound Treatment Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Therapy
        • 7.3.5.2.2. By Wound Type
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End User

8. Asia Pacific Wound Treatment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Therapy
    • 8.2.2. By Wound Type
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Wound Treatment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Therapy
        • 8.3.1.2.2. By Wound Type
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. India Wound Treatment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Therapy
        • 8.3.2.2.2. By Wound Type
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan Wound Treatment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Therapy
        • 8.3.3.2.2. By Wound Type
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea Wound Treatment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Therapy
        • 8.3.4.2.2. By Wound Type
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Wound Treatment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Therapy
        • 8.3.5.2.2. By Wound Type
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. Middle East & Africa Wound Treatment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Therapy
    • 9.2.2. By Wound Type
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Wound Treatment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Therapy
        • 9.3.1.2.2. By Wound Type
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. UAE Wound Treatment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Therapy
        • 9.3.2.2.2. By Wound Type
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. South Africa Wound Treatment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Therapy
        • 9.3.3.2.2. By Wound Type
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User

10. South America Wound Treatment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Therapy
    • 10.2.2. By Wound Type
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Wound Treatment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Therapy
        • 10.3.1.2.2. By Wound Type
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Colombia Wound Treatment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Therapy
        • 10.3.2.2.2. By Wound Type
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. Argentina Wound Treatment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Therapy
        • 10.3.3.2.2. By Wound Type
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Wound Treatment Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. 3M Company
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. ConvaTec Group PLC
  • 15.3. MOlnlycke Health Care AB
  • 15.4. Smith & Nephew plc
  • 15.5. Organogenesis Incx
  • 15.6. Coloplast A/S
  • 15.7. MiMedx Group Inc.
  • 15.8. Integra LifeSciences Corporation
  • 15.9. Johnson & Johnson
  • 15.10. Medtronic Plc

16. Strategic Recommendations

17. About Us & Disclaimer